| Application no. and date | 12195108.1 (espacenet) (Federated) (European Patent Register), 20060601 | | Patent/reg. no. and date | DK/EP 2564843, 20181226 | | Publication date | 20130306 | | Priority no. and date | US 686826 P, 20050601, US 701815 P, 20050721, US 776028 P, 20060222 | | EP pub. no. and date |
EP 2564843 20130306 | | Effective date | | | Applicant/owner | PTC Therapeutics, Inc., 100 Corporate Court
Middlesex Business Center
South Plainfield, NJ 07080, US | | Applicant ref. no. | P81900719DK00E | | Inventor | Miller, Guy M.,, Edison Pharmaceuticals, Inc.
350 North Bernardo Avenue
Mountain View, CA California 94043, US,
Hecht, Sidney M.,, University of Virginia
Dept. of Chemistry
McCormick Road
P.O.Box 400319
Charlottesville, VA Virginia 22904-4319, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/355 (2006.01) , A61P 25/28 (2006.01) , A61P 3/00 (2006.01) | | Title | Redox-aktive terapeutiske midler til behandling af mitokondriesygdomme og andre tilstande samt modulering af energibiomarkører | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
